ACM Research (ACMR) Cash & Equivalents (2016 - 2026)

ACM Research (ACMR) has reported Cash & Equivalents for 11 consecutive years, with $872.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 90.77% year-over-year to $872.3 million; the TTM figure through Mar 2026 stood at $872.3 million (up 90.77% YoY), while the FY2025 annual figure was $757.4 million, up 85.88% from the prior year.
• Cash & Equivalents rose to $872.3 million in Q1 2026 per ACMR's latest filing, from $757.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.1 billion in Q3 2025 and bottomed at $182.1 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $415.3 million across 5 years, with a median of $333.5 million in 2024.
• On a YoY basis, Cash & Equivalents climbed as much as 421.22% in 2022 and fell as far as 55.92% in 2022.
• ACM Research's Cash & Equivalents stood at $248.0 million in 2022, then decreased by 26.56% to $182.1 million in 2023, then surged by 123.76% to $407.4 million in 2024, then soared by 85.88% to $757.4 million in 2025, then climbed by 15.17% to $872.3 million in 2026.
• Business Quant data shows ACMR's Cash & Equivalents at $872.3 million in Q1 2026, $757.4 million in Q4 2025, and $1.1 billion in Q3 2025.